USH2A and Usher syndrome: Our results suggest that up to 90 % of USH patients are due to mutations in known USH disease genes when including patients with monoallelic mutations in USH2A. By combining molecular diagnosis and patient clinical information, a more accurate diagnosis, prognoses and personalized treatment of individual USH patients can be achieved.